- Micro focus investor relations full#
- Micro focus investor relations software#
- Micro focus investor relations professional#
Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Notice regarding Forward Looking Statements and Legal Disclaimer To sign up for updates relating to Nanalysis, please complete the online form found HERE.
Micro focus investor relations software#
Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology.
Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Nanalysis operates out of two subsidiaries, Nanalysis Corp. Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', Over the Counter (OTC) in the United States under the ticker symbol 'NSCIF', and on the Frankfurt Exchange (FRA) under the symbol '1N1'. The agreement is subject to the acceptance of the TSX Venture Exchange.Ībout Nanalysis Scientific Corp. The term of the agreement is for twelve months and may be cancelled subsequently, in writing, with standard notice provisions.
Micro focus investor relations full#
I don't believe the market has recognized Nanalysis' full value and I am looking forward to working with the team to enhance exposure to the investment community."įirm IR Group will receive US$7,000 per month commencing October 15, 2021, and 50,000 options for common shares at $1.24 vesting quarterly over twelve months. "The company is well capitalized, has recently bolstered their production capacity to meet growing demand, and their backlog demonstrates their ability to continue to deliver on their strategy with consistent and compelling growth for the foreseeable future. "The team at Nanalysis continues to execute in their pursuit of disrupting the industrial and medical MRI spaces," said Matthew Selinger, Principal at Firm IR Group.
Micro focus investor relations professional#
We are engaging an experienced professional to leverage our story and bring enhanced visibility through strong relationships." Hiring Firm IR Group will mirror our broader corporate strategy onto our communications strategy.
"Over the past year we have made a concerted effort in our sales, manufacturing and acquisition strategy to grow sales and product offerings. "We are continually looking to see how we can improve our business and we believe that enhancing our Investor Relations falls in line with our corporate strategy," said Sean Krakiwsky, Chief Executive Officer of Nanalysis. Logo (CNW Group/Nanalysis Scientific Corp.)
0 kommentar(er)
